Syneos Health DPO Ratio 2011-2026 | SYNH

Annual DPO Ratio Syneos Health

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
10.1	-	13.7	10.5	10.4	7.17	8	6.83	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
13.7	6.83	9.53

Quarterly DPO Ratio Syneos Health

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
11.1	-	-	-	9.43	-	9.64	10.2	11	-	12.7	12.9	12.4	-	13.7	13.6	12.1	-	10.3	10.6	8.53	-	-	18.1	13.2	-	7.41	7.2	6.67	-	8.17	8.28	7.99	-	6.85	7.09	5.88	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
18.1	5.88	10.2

DPO Ratio of other stocks in the Diagnostics research industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	120	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	21.3	-	-17.87 %	$ 25.9 M	Canada
Bioventus BVS	35.1	$ 8.98	1.18 %	$ 598 M	USA
Castle Biosciences CSTL	52	$ 26.0	0.64 %	$ 722 M	USA
Aspira Women's Health AWH	112	-	-6.19 %	$ 10.5 M	USA
DexCom DXCM	67.7	$ 68.09	2.64 %	$ 26.6 B	USA
Guardant Health GH	48.6	$ 88.7	1.74 %	$ 11.1 B	USA
Oxford Immunotec Global PLC OXFD	45.8	-	-	$ 562 M	Britain
Charles River Laboratories International CRL	24.5	$ 155.4	2.26 %	$ 7.7 B	USA
CareDx, Inc CDNA	44.2	$ 17.57	1.44 %	$ 936 M	USA
ICON Public Limited Company ICLR	6.52	$ 101.48	3.96 %	$ 8.37 B	Irlanda
IQVIA Holdings IQV	126	$ 169.45	2.77 %	$ 29.1 B	USA
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	49.2	$ 103.94	0.08 %	$ 19.6 B	USA
Global Cord Blood Corporation CO	17.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	61.4	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	780	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	43.5	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	34.9	$ 15.65	4.65 %	$ 473 M	USA
PRA Health Sciences, Inc. PRAH	8.98	-	-	$ 10.7 B	USA
Anixa Biosciences ANIX	1.29 K	$ 2.88	1.23 %	$ 93.5 K	USA
Neogen Corporation NEOG	62.7	$ 9.37	2.85 %	$ 2.03 B	USA
Danaher Corporation DHR	65.4	$ 194.76	1.76 %	$ 139 B	USA
Biocept BIOC	56.3	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	39.7	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	112	-	-20.0 %	$ 1.06 M	USA
Pacific Biosciences of California PACB	59.7	$ 1.4	3.16 %	$ 420 M	USA
Illumina ILMN	56.3	$ 121.73	2.05 %	$ 19.4 B	USA
Quest Diagnostics Incorporated DGX	14.7	$ 199.39	0.23 %	$ 22.1 B	USA
QIAGEN N.V. QGEN	50	-	-	$ 10.6 B	Niderland
Agilent Technologies A	50.1	$ 113.69	1.66 %	$ 34.6 B	USA
BioNano Genomics BNGO	104	$ 1.12	0.9 %	$ 1.42 M	USA
DarioHealth Corp. DRIO	43.9	$ 9.28	10.24 %	$ 263 M	Israel
Lantheus Holdings LNTH	23.6	$ 78.71	0.26 %	$ 5.31 B	USA
Chembio Diagnostics CEMI	52.5	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	106	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	13.3	$ 457.78	0.91 %	$ 13.2 B	USA
Motus GI Holdings MOTS	1.72	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	53.4	$ 1 218.18	1.62 %	$ 25.1 B	Schweiz
DermTech DMTK	47.4	-	-11.32 %	$ 2.94 M	USA
Twist Bioscience Corporation TWST	12.5	$ 46.28	2.82 %	$ 2.77 B	USA
National Research Corporation NRC	10.1	$ 18.07	3.85 %	$ 404 M	USA
NeoGenomics NEO	19.7	$ 8.41	2.06 %	$ 1.08 B	USA
Invitae Corporation NVTA	69	-	-	$ 21.2 M	USA
Enzo Biochem ENZ	52.3	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	17.9	$ 201.38	1.87 %	$ 19.8 B	USA